Most practitioners know the operational benefits of group and concurrent therapy, which is rising in popularity since the implementation of the Patient Driven Payment Model (PDPM), current staffing shortages, and the decrease in a need for isolation and quarantines during the pandemic. This session will review the clinical benefits and regulatory guidelines of group and concurrent therapy to enable practitioners to make effective and ethical treatment decisions.